Brachial plexus bridging with specific extracellular matrix-modified chitosan/silk scaffold: a new expand of tissue engineered nerve graft

J Neural Eng. 2022 Mar 25;19(2). doi: 10.1088/1741-2552/ac5b95.

Abstract

Objective.Brachial plexus injuries (BPIs) result in serious dysfunction, especially brachial plexus defects which are currently treated using autologous nerve graft (autograft) transplantation. With the development of tissue engineering, tissue engineered nerve grafts (TENGs) have emerged as promising alternatives to autografts but have not yet been widely applied to the treatment of BPIs. Herein, we developed a TENG modified with extracellular matrix generated by skin-derived precursor Schwann cells (SKP-SCs) and expand its application in upper brachial plexus defects in rats.Approach.SKP-SCs were co-cultured with chitosan neural conduits or silk fibres and subjected to decellularization treatment. Ten bundles of silk fibres (five fibres per bundle) were placed into a conduit to obtain the TENG, which was used to bridge an 8 mm gap in the upper brachial plexus. The efficacy of this treatment was examined for TENG-, autograft- and scaffold-treated groups at several times after surgery using immunochemical staining, behavioural tests, electrophysiological measurements, and electron microscopy.Main results.Histological analysis conducted two weeks after surgery showed that compared to scaffold bridging, TENG treatment enhanced the growth of regenerating axons. Behavioural tests conducted four weeks after surgery showed that TENG-treated rats performed similarly to autograft-treated ones, with a significant improvement observed in both cases compared with the scaffold treatment group. Electrophysiological and retrograde tracing characterizations revealed that the target muscles were reinnervated in both TENG and autograft groups, while transmission electron microscopy and immunohistochemical staining showed the occurrence of the superior myelination of regenerated axons in these groups.Significance.Treatment with the developed TENG allows the effective bridging of proximal nerve defects in the upper extremities, and the obtained results provide a theoretical basis for clinical transformation to expand the application scope of TENGs.

Keywords: brachial plexus injuries (BPIs); function recovery; nerve regeneration; skin-derived precursor Schwann cells (SKP-SCs); tissue engineered nerve grafts (TENGs).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brachial Plexus* / surgery
  • Chitosan* / chemistry
  • Chitosan* / pharmacology
  • Extracellular Matrix
  • Nerve Regeneration
  • Rats
  • Rats, Sprague-Dawley
  • Schwann Cells / transplantation
  • Sciatic Nerve
  • Silk / chemistry
  • Silk / pharmacology
  • Tissue Engineering / methods
  • Tissue Scaffolds / chemistry

Substances

  • Silk
  • Chitosan